曼月乐治疗原发性痛经的临床观察(1)
 |
| 第1页 |
参见附件。
[摘要] 目的 探讨放置左炔诺酮宫内节育器(LNG—IUS，曼月乐)对原发性痛经患者的治疗效果。 方法 回顾性研究2008年2月～2011年1月我院妇科门诊原发性痛经患者50例，分为A组21例放置曼月乐作为研究组，B组29例给予口服避孕药治疗作为对照组，观察50例患者放置曼月乐及口服避孕药后连续随访3个月的痛经程度。 结果 治疗30 d、60 d、90 d后，两组患者的子宫体积比较，差异无统计学意义(P > 0.05)。治疗30 d、60 d、90 d后，两组的月经量和VAS评分比较，差异有统计学意义(P < 0.05)。 结论 曼月乐是治疗原发性痛经一种较为有效且安全的方法。
[关键词] 原发性痛经；左炔诺酮宫内节育器
[中图分类号] R711.3 [文献标识码] B [文章编号] 1673—9701(2012)26—0157—02
The clinical observation of Mirena in the treatment of primary dysmenorrheal
MA Qiang DONG Wu BAI Feng WANG Yajuan
Department of Obstetrics and Gynaecology，the People's Hospital of Liaoning Province， Shenyang 110016，China
[Abstract] Objective To investigate the effect of Levonorgestrel—releasing intrauterine device (LNG—IUD， Mirena) placed in patients with primary dysmenorrhea. Methods All of 50 cases of gynecological patients were retrospectively analyzed form February 2008 to January 2011 in our hospital. Group A(21 patients) were treated with Mirena as test group， Group B(29 patients)were treated with oral contraceptive as control group. 50 patients were followed up in 1， 2， 3 months after treatment. Results The uterine volume of 30 days，60 days and 90 days after the treatment was no significant difference between Group A and Group B(P > 0.05). However， the menstrual quantity and the dysmenorrheal score of 30 days， 60 days and 90 days after treatment had significant difference between two groups(P < 0.05). Conclusion Mirena is an effective and safe therapy for primary dysmenorrhea.
[Key words] Primary dysmenorrhea；Levonorgestrel—releasing intrauterine device
痛经为妇科最常见的症状之一，是指行经前后或月经期出现下腹部疼痛、坠胀、伴有腰酸或其他不适，症状严重者影响生活质量。痛经分为原发性和继发性两类，原发性痛经是指生殖器官无器质性病变 ......
您现在查看是摘要介绍页，详见PDF附件(2055kb)。